Literature DB >> 12244168

Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25+ cells, and the alloreactive T cell clone size.

Masayuki Sho1, Akira Yamada, Nader Najafian, Alan D Salama, Hiroshi Harada, Sigrid E Sandner, Alberto Sanchez-Fueyo, Xin Xiao Zheng, Terry B Strom, Mohamed H Sayegh.   

Abstract

The mechanisms underlying physiological regulation of alloimmune responses remain poorly defined. We investigated the roles of cytokines, CTLA-4, CD25(+) T cells, and apoptosis in regulating alloimmune responses in vivo. Two murine cardiac transplant models were used, B10.D2 (minor mismatch) and C57BL/6 (major mismatch), into BALB/c recipients. Recipients were wild type, STAT4(-/-) (Th1 deficient), or STAT6(-/-) (Th2 deficient) mice. Minor mismatched allografts were accepted spontaneously in approximately 70% of wild type and STAT4(-/-) mice. By contrast, there was significantly shorter graft survival in minor mismatched STAT6(-/-) mice. Either the adoptive transfer of STAT4(-/-) splenocytes or the administration of IL-4Fc fusion protein into STAT6(-/-) mice resulted in long term graft survival. Blocking CTLA-4 signaling accelerated the rejection in all recipients, but was more pronounced in the minor combination. This was accompanied by an increased frequency of alloreactive T cells. Furthermore, CTLA-4 blockade regulated CD4(+) or CD8(+) as well as Th1 or Th2 alloreactive T cells. Finally, while anti-CD25 treatment prolonged graft survival in the major mismatched combination, the same treatment accelerated graft rejection in the minor mismatched group. The latter was associated with an increased frequency of alloreactive T cells and inhibition of T cell apoptosis. These data demonstrate that cytokine regulation, CTLA-4 negative signaling, and T cell apoptosis play critical roles in regulating alloimmunity, especially under conditions where the alloreactive T cell clone size is relatively small.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244168     DOI: 10.4049/jimmunol.169.7.3744

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity.

Authors:  Hiroshi Harada; Alan D Salama; Masayuki Sho; Atsushi Izawa; Sigrid E Sandner; Toshiro Ito; Hisaya Akiba; Hideo Yagita; Arlene H Sharpe; Gordon J Freeman; Mohamed H Sayegh
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

Review 2.  Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits.

Authors:  Renaud Snanoudj; Julien Zuber; Christophe Legendre
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

3.  Requirements for induction and maintenance of peripheral tolerance in stringent allograft models.

Authors:  Masayuki Sho; Koji Kishimoto; Hiroshi Harada; Mauren Livak; Alberto Sanchez-Fueyo; Akira Yamada; Xin Xiao Zheng; Terry B Strom; Giacomo P Basadonna; Mohamed H Sayegh; David M Rothstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

Review 4.  Transplant tolerance: models, concepts and facts.

Authors:  Nicola J Monk; Roseanna E G Hargreaves; Elizabeth Simpson; Julian P Dyson; Stipo Jurcevic
Journal:  J Mol Med (Berl)       Date:  2006-02-25       Impact factor: 4.599

5.  Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure.

Authors:  Marina Afanasyeva; Dimitrios Georgakopoulos; Diego F Belardi; Djahida Bedja; Delisa Fairweather; Yan Wang; Ziya Kaya; Kathleen L Gabrielson; E Rene Rodriguez; Patrizio Caturegli; David A Kass; Noel R Rose
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

6.  TIM-1 signaling is required for maintenance and induction of regulatory B cells.

Authors:  M Y Yeung; Q Ding; C R Brooks; S Xiao; C J Workman; D A A Vignali; T Ueno; R F Padera; V K Kuchroo; N Najafian; D M Rothstein
Journal:  Am J Transplant       Date:  2015-02-02       Impact factor: 8.086

7.  Co-inhibitory molecules: Controlling the effectors or controlling the controllers?

Authors:  Govindarajan Thangavelu; Christa Smolarchuk; Colin C Anderson
Journal:  Self Nonself       Date:  2010-02-16

Review 8.  Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis.

Authors:  Kristen Hayward; Carol A Wallace
Journal:  Arthritis Res Ther       Date:  2009-02-23       Impact factor: 5.156

9.  Clinical importance of B7-H3 expression in human pancreatic cancer.

Authors:  I Yamato; M Sho; T Nomi; T Akahori; K Shimada; K Hotta; H Kanehiro; N Konishi; H Yagita; Y Nakajima
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

10.  The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept.

Authors:  Renaud Snanoudj; Carlos Frangié; Benjamin Deroure; Hélène François; Caroline Créput; Séverine Beaudreuil; Antoine Dürrbach; Bernard Charpentier
Journal:  Biologics       Date:  2007-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.